跳到正文
原文
Nature 健康护理主题·· 2026-10-01AI 评分48

Scientific Reports发表研究:脂肪组织与胰岛素抵抗指数与中国成年人心血管-肾脏-代谢综合征进展的相关性

Adiposity and insulin resistance indices and progression to advanced cardiovascular-kidney-metabolic syndrome in Chinese adults

AI 导读

这项基于中国健康与退休纵向调查(CHARLS)2871名基线CKM 0-2期参与者的前瞻性分析发现,7项代谢与脂肪组织指数(如TyG-WC)升高与CKM进展至3-4期风险增加相关。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Metabolic and adiposity-related indices may help identify individuals at increased risk of cardiovascular-kidney-metabolic (CKM) progression; however, comparative prospective evidence remains limited. We examined the associations of seven metabolic and adiposity-related indices with progression to advanced CKM stages and assessed their incremental discrimination and exploratory internal machine-learning performance. This prospective analysis included 2,871 participants from the China Health and Retirement Longitudinal Study with CKM stages 0–2 at baseline in 2011. CKM progression was defined as progression to stages 3–4 at the 2015 follow-up. Associations of the triglyceride-glucose index (TyG), TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), lipid accumulation product (LAP), visceral adiposity index (VAI), waist-to-height ratio (WHtR), and body roundness index (BRI) with CKM progression were examined using multivariable Cox regression after multiple imputation. Dose–response, subgroup, sensitivity, and incremental discrimination analyses were performed. Separate LAP-, TyG-WC-, and TyG-WHtR-based machine-learning frameworks were evaluated using a stratified 70:30 training/test split. During follow-up, 595 participants (20.7%) progressed to CKM stages 3–4. In fully adjusted analyses, the highest versus lowest quartile of each index was associated with a higher risk of CKM progression, with HRs ranging from 1.52 for TyG (95% CI, 1.20–1.94) to 2.03 for TyG-WC (95% CI, 1.60–2.57; all P for trend < 0.001). Corresponding HRs were 2.01 (95% CI, 1.57–2.57) for TyG-WHtR and 1.98 (95% CI, 1.55–2.54) for LAP. Six indices showed nonlinear dose–response associations. Subgroup analyses showed significant interactions by sex for TyG-WHtR, LAP, WHtR, BRI, and VAI; by smoking status for TyG-WHtR, LAP, and VAI; and by age for WHtR (all P for interaction ≤ 0.049). Addition of individual indices to the covariate model yielded C-indices of 0.702–0.715, compared with 0.701 for the basic model; TyG-WC achieved the highest C-index. In the held-out internal test set, logistic regression achieved the highest ROC-AUC in the LAP (0.721), TyG-WC (0.729), and TyG-WHtR (0.726) frameworks. SHAP analyses of the corresponding logistic regression models identified age as the predictor with the largest mean absolute contribution across all three frameworks. Elevated levels of all seven indices were associated with CKM progression, particularly TyG-WC, TyG-WHtR, and LAP. Given the structural overlap between several index components and the CKM staging framework, the incremental discrimination and machine-learning findings should be considered exploratory and require external validation.

Similar content being viewed by others

Acknowledgements

The authors thank the China Health and Retirement Longitudinal Study team and all study participants for providing the data used in this analysis.

Funding

This study was supported by the Research Project of Traditional Chinese Medicine, Heilongjiang Provincial Administration of Traditional Chinese Medicine (Grant No. ZHY2024-024), and by the Hospital-level Talent Special Fund of the Fourth Hospital of Heilongjiang University of Traditional Chinese Medicine (Grant No. FSRC2024ZD02).

Author information

Author notes

  1. Zhe Jiang and JingLu Zhang contributed equally to this work.

Authors and Affiliations

  1. Heilongjiang University of Chinese Medicine, Harbin, 150040, China

    Zhe Jiang & JingLu Zhang

  2. The Fourth Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang Province, China

    XiaoDong Zhang & LiXia Jin

Authors

  1. Zhe Jiang
  2. JingLu Zhang
  3. XiaoDong Zhang
  4. LiXia Jin

Corresponding author

Correspondence to LiXia Jin.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The CHARLS study was approved by the Biomedical Ethics Review Committee of Peking University (IRB00001052-11015). All participants provided written informed consent before participation. The present study was a secondary analysis of de-identified CHARLS data and was conducted in accordance with the Declaration of Helsinki.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, Z., Zhang, J., Zhang, X. et al. Adiposity and insulin resistance indices and progression to advanced cardiovascular-kidney-metabolic syndrome in Chinese adults. Sci Rep (2026). https://doi.org/10.1038/s41598-026-73815-x

Download citation

  • Received: 17 October 2025

  • Accepted: 25 September 2026

  • Published: 01 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-73815-x

Keywords

来源:Nature 健康护理主题 · nature.com